v3.22.0.1
COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Option Activity
The following table summarizes the Company’s option activity during the years ended December 31, 2021, 2020 and 2019:
Years ended December 31 2021 2020 2019
(shares in thousands) Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Outstanding beginning of year 1,015  $ 43.88  536  $ 45.11  545  $ 44.35 
Granted during the year     495  42.87  —  — 
Forfeited during the year (32) 41.33  (4) 54  —  — 
Exercised during the year (615) 44.11  (12) 53.83  (9) 0.67 
Outstanding end of year 368  $ 43.72  1,015  $ 43.88  536  $ 45.11 
Vested Options:
Vested during the year 248  $ 46.70  115  $ 50.46  115  $ 50.46 
Eligible end of year for exercise 67  $ 47.05  439  $ 43.19  336  $ 41.07 
Aggregate intrinsic value ($ in thousands):
Total options outstanding $ 13,593  $ 24,838  $ 4,398 
Options exercisable $ 2,268  $ 11,047  $ 4,051 
Options exercised $ 26,348  $ 97  $ 381 
Weighted average fair value of options granted during the year N/A $ 15.17  N/A
The following table summarizes the Company’s SARS activity during the years ended December 31, 2021, 2020 and 2019:
Years ended December 31 2021 2020 2019
(shares in thousands) Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Total SARS:
Outstanding beginning of year 485  $ 56.96  535  $ 54.53  535  $ 54.53 
Granted during the year     —  —  —  — 
Forfeited during the year     (10) 68.01  —  — 
Exercised during the year (261) 50.63  (40) 22.39  —  — 
Outstanding end of year 224  $ 64.33  485  $ 56.96  535  $ 54.53 
Vested SARS:
Vested during the year 85  $ 63.86  115  $ 60.71  115  $ 60.71 
Eligible end of year for exercise 224  $ 64.33  404  $ 55.58  336  $ 50.04 
Aggregate intrinsic value ($ in thousands):
Total SARS outstanding $ 3,669  $ 6,032  $ 3,190 
SARS exercisable $ 3,669  $ 5,540  $ 3,066 
SARS exercised $ 9,045  $ 1,918  $ — 
Weighted average fair value of SARS granted during the year N/A N/A N/A
Schedule of Black-scholes Model for Awards Granted
The following table presents assumptions used in the Black-Scholes model for the stock options granted in 2020. There were no stock options granted in 2021 and 2019.
  2020
Dividend rate 2.37  %
Risk-free interest rate 0.65  %
Expected option life (years) 5.0
Price volatility 42.42  %
Schedule of Award Activity
The following table summarizes the activity for restricted stock for the years ended December 31, 2021, 2020 and 2019:  
  2021 2020 2019
(shares in thousands) Shares Weighted-Average
Grant Date
Stock Price
Shares Weighted-Average
Grant Date
Stock Price
Shares Weighted-Average
Grant Date
Stock Price
Unvested beginning of year 790  $ 50.39  738  $ 49.65  606  $ 48.56 
Granted during the year 371  67.27  309  55.03  378  39.74 
Vested during the year (198) 60.05  (178) 52.80  (230) 30.46 
Forfeited during the year (34) 50.37  (79) 55.87  (16) 50.49 
Unvested end of year 929  $ 55.06  790  $ 50.39  738  $ 49.65